24.6 C
New York
Sunday, June 14, 2026

Tag: research

newssourceFORcompanyinformationcontent1marketreleases

Haleon Announces ~₹2000 Crore Total Investment to Set Up its First Manufacturing Facility in India

Greenfield facility in Madhya Pradesh to support 'Make in India' vision and strengthen Haleon's commitment to delivering better everyday healthStrategic oral health-focused site designed...

THE POWER OF PLAY: NEW RESEARCH CONFIRMS JUST SECONDS OF PLAY INSTANTLY BRING FAMILIES CLOSER

Findings from Phase 2 of the "Power of Play: Family Connection" study from Kinder and the University of East London (UEL) confirm that shared...

Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026

ZUG, Switzerland, June 11, 2026 – Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announced an upcoming presentation at Clinical Trials at the Summit 2026, taking place on June 12-13, 2026, in Las Vegas, Nevada.

Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026

ZUG, Switzerland, June 11, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announced an upcoming presentation at Clinical Trials at the Summit 2026, taking place on June 12-13, 2026, in Las Vegas, Nevada.

Scenic Biotech Joins Michael J. Fox Foundation’s LITE Program to Explore New Disease-Modifying Approach for Parkinson’s Disease

Scenic Biotech Joins Michael J. Fox Foundation’s LITE Program to Explore New Disease-Modifying Approach for Parkinson's Disease

Hope and inspiration: China-Greece cultural dialogue’s contemporary relevance

BEIJING, June 11, 2026 /PRNewswire/ -- A report from People's Daily: The second World Conference of Classics convened on June 9 and 10 in Athens,...

IMAAVY® (nipocalimab-aahu) demonstrates durable hemoglobin response and rapid onset of effect in pivotal Phase 2/3 study in warm autoimmune hemolytic anemia (wAIHA), an autoantibody-driven...

Patients in the IMAAVY 30 mg/kg treatment groupa achieved statistically significant durable hemoglobin responseb, with mean hemoglobin improvement of at least 1 g/dL as...

Proof of Pitch Returns to the Louvre and Names Its 2026 Winners

PARIS, June 11, 2026 (GLOBE NEWSWIRE) -- Proof of Pitch returned to the Louvre Palace on June 2 and 3 for its fourth edition, and two startups left Paris as winners. ReplyCorp took the General Track, and Parthenon won the Canton Track after live pitches in front of one of the strongest investor juries in Web3.

Vivoryon Therapeutics N.V. Reports Q1 2026 Financial Results and Provides Business Update

Vivoryon Therapeutics N.V. Reports Q1 2026 Financial Results
and Provides Business Update

Joybuy launches first ‘Summer Black Friday’ for UK shoppers – no need to wait for winter for unbeatable deals

Almost half of UK consumers want a Summer Black Friday Promotion, new Independent research shows*Black Friday offers, but hotter: Joybuy's Summer Black Friday offers...

Hainan emerging as hub for export of digital content, culture

HAIKOU, China, June 11, 2026 /PRNewswire/ -- A news report from chinadaily.com.cn Hainan province is doubling down on its digital economy, leveraging free trade port...

Hainan emerging as hub for export of digital content, culture

HAIKOU, China, June 11, 2026 /PRNewswire/ -- A news report from chinadaily.com.cn ...

Manulife Asia Care Survey 2026: Independence as Asia’s New Legacy

From living longer to living free, people across Asia prioritize health and financial self-sufficiency to pursue independence and avoid burdening loved onesHONG KONG, June...

Manulife Asia Care Survey 2026: Independence as Asia’s New Legacy

From living longer to living free, people across Asia prioritize health and financial self-sufficiency to pursue independence and avoid burdening loved onesHONG KONG, June...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsResearch

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers